Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens. How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibiotic-associated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“pathogen burden is reduced upon infection of mice monocolonized with a sialidase-deficient B. thetaiothaomicron strain [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“In mono-associated gnotobiotic mice, B. thetaiothaomicron-liberated sialic acid can support the expansion of pathogens such as C. difficile or S. enterica upon oral infection.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“In conventional mice, antibiotics reduce the amount of commensals competing for sugars liberated prior to treatment, increasing nutrient availability and favoring pathogen expansion througha limited time-window (peaking at day 1 and ending at day 3 post-antibiotic treatment for this study) [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“B. thetaiotaomicron also carries sialidases that can cleave sialic acid from mucus, although the bacterium lacks the enzymatic machinery necessary to catabolize such sugar [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Self-citationDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context
Lozupone, C., Hamady, M., & Knight, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-371 · Cited by 1,453
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Research works printed but not linked: 3
- Martens EC Chiang HC Gordon JI Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont Cell host & microbe 2008 4 447 457 18996345 PMC2605320
- Chen X A mouse model of Clostridium difficile-associated disease Gastroenterology 2008 135 6 1984 1992 18848941
- Sonnenburg JL Glycan foraging in vivo by an intestine-adapted bacterial symbiont Science 2005 307 5717 1955 1959 15790854
Cited by
Items 101–200 of 1,000
Ng, K. M., Aranda-Díaz, A., Tropini, C., Frankel, M. R., Van Treuren, W., O’Loughlin, C. T., Merrill, B. D., Yu, F. B., Pruss, K. M., Oliveira, R. A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.011 · Cited by 273
Self-citationMicrobial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria
Knoop, K. A., Gustafsson, J. K., McDonald, K. G., Kulkarni, D. H., Coughlin, P. E., McCrate, S., Kim, D., Hsieh, C.-S., Hogan, S. P., Elson, C. O., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aao1314 · Cited by 270
Sorbara, M. T., Dubin, K., Littmann, E. R., Moody, T. U., Fontana, E., Seok, R., Leiner, I. M., Taur, Y., Peled, J. U., van den Brink, M. R. M., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181639 · Cited by 259
Bacteroides and related species: The keystone taxa of the human gut microbiota
Shin, J. H., Tillotson, G., MacKenzie, T. N., Warren, C. A., Wexler, H. M., & Goldstein, E. J. C. (2024) · Anaerobe · doi:10.1016/j.anaerobe.2024.102819 · Cited by 242
Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice
Huang, Y.-L., Chassard, C., Hausmann, M., von Itzstein, M., & Hennet, T. (2015) · Nature Communications · doi:10.1038/ncomms9141 · Cited by 243
A microbial perspective of human developmental biology
Charbonneau, M. R., Blanton, L. V., DiGiulio, D. B., Relman, D. A., Lebrilla, C. B., Mills, D. A., & Gordon, J. I. (2016) · Nature · doi:10.1038/nature18845 · Cited by 250
The Critical Roles of Polysaccharides in Gut Microbial Ecology and Physiology
Porter, N. T., & Martens, E. C. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095316 · Cited by 249
Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
Fang, J., Wang, H., Zhou, Y., Zhang, H., Zhou, H., & Zhang, X. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00617-8 · Cited by 240
Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
Hryckowian, A. J., Van Treuren, W., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0150-6 · Cited by 248
“88137, Harlan); or (4) a custom diet containing inulin as the sole MAC source47, which is based on the MD1 diet (58% glucose (w/v), 10% inulin (w/v) (Orafti HP, Beneo-Orafti group), 18% protein (w/v) and 7% fat (w/v) (Bio-Serv)).”
Self-citationSiegel, S. J., Roche, A. M., & Weiser, J. N. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.005 · Cited by 247
“In the gut, sialic acid released by the sialidase of one bacterial species can promote sialic acid catabolism-dependent growth of another (Ng et al., 2013).”
BackgroundStecher, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0008-2014 · Cited by 237
Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome
Whitaker, W. R., Shepherd, E. S., & Sonnenburg, J. L. (2017) · Cell · doi:10.1016/j.cell.2017.03.041 · Cited by 244
Self-citationMicrobiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Community assembly of a euryhaline fish microbiome during salinity acclimation
Schmidt, V. T., Smith, K. F., Melvin, D. W., & Amaral‐Zettler, L. A. (2015) · Molecular Ecology · doi:10.1111/mec.13177 · Cited by 237
Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
Pandiyan, P., Bhaskaran, N., Zou, M., Schneider, E., Jayaraman, S., & Huehn, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00426 · Cited by 236
Herath, M., Hosie, S., Bornstein, J. C., Franks, A. E., & Hill-Yardin, E. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00248 · Cited by 213
Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease
Flynn, J. M., Niccum, D., Dunitz, J. M., & Hunter, R. C. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005846 · Cited by 235
Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut
Lim, B., Zimmermann, M., Barry, N. A., & Goodman, A. L. (2017) · Cell · doi:10.1016/j.cell.2017.03.045 · Cited by 222
The function of gut microbiota in immune-related neurological disorders: a review
Sittipo, P., Choi, J., Lee, S., & Lee, Y. K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02510-1 · Cited by 221
“The products of mucus degradation can be utilized by other gut microbiota, such as Lachnospiraceae [103], Clostridium cluster XIV [104], Clostridium difficile [105], and Enterobacteriaceae [106].”
BackgroundCommensal bacteria mediated defenses against pathogens
Abt, M. C., & Pamer, E. G. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.003 · Cited by 212
The promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217
Self-citationReprograming of gut microbiome energy metabolism by the FUT2 Crohn’s disease risk polymorphism
Tong, M., McHardy, I., Ruegger, P., Goudarzi, M., Kashyap, P. C., Haritunians, T., Li, X., Graeber, T. G., Schwager, E., Huttenhower, C., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.64 · Cited by 207
Self-citationSalmonella versus the Microbiome
Rogers, A. W. L., Tsolis, R. M., & Bäumler, A. J. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-19 · Cited by 205
Studer, N., Desharnais, L., Beutler, M., Brugiroux, S., Terrazos, M. A., Menin, L., Schürch, C. M., McCoy, K. D., Kuehne, S. A., Minton, N. P., et al. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00191 · Cited by 195
“We compared this new model to previously established CDI models including completely axenic (germ-free) mice (Pawlowski et al., 2010), antibiotic- (streptomycin- and clindamycin-) pretreated SPF mice (Buffie et al., 2011; Ng et al., 2013) and unmanipulated (and highly CDI resistant) SPF mice.”
BackgroundResultInfluentialSchwab, C., Ruscheweyh, H.-J., Bunesova, V., Pham, V. T., Beerenwinkel, N., & Lacroix, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00095 · Cited by 187
The germ-organ theory of non-communicable diseases
Byndloss, M. X., & Bäumler, A. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.158 · Cited by 186
Egan, M., O’Connell Motherway, M., Kilcoyne, M., Kane, M., Joshi, L., Ventura, M., & van Sinderen, D. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0282-7 · Cited by 192
“Similarly, Salmonella typhimurium and Clostridium difficile have been shown to utilize sialic acid released by the sialidase activity of Bacteroides thetaotaomicron in a gnotobiotic mouse [71].”
BackgroundGut Microbial Succession Follows Acute Secretory Diarrhea in Humans
David, L. A., Weil, A., Ryan, E. T., Calderwood, S. B., Harris, J. B., Chowdhury, F., Begum, Y., Qadri, F., LaRocque, R. C., & Turnbaugh, P. J. (2015) · mBio · doi:10.1128/mbio.00381-15 · Cited by 192
The interplay between host immune cells and gut microbiota in chronic inflammatory diseases
Kim, D., Zeng, M. Y., & Núñez, G. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.24 · Cited by 181
Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats
Iacob, S., Iacob, D. G., & Luminos, L. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03328 · Cited by 177
Dysbiosis in intestinal inflammation: Cause or consequence
Buttó, L. F., & Haller, D. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.010 · Cited by 188
“…enter- ca serovar Typhimurium and Clostridium difficile (Keeney and inlay, 2011; Ng et al., 2013), Enterococcus ssp. (Kinnebrew et al., 010; Ocvirk et al., 2015) and Escherichia ssp. (Patwa et al., 2011; chaptchet et al., 2013), which benefit from the resulting perturation of the…”
BackgroundInfluentialRespiration of Microbiota-Derived 1,2-propanediol Drives Salmonella Expansion during Colitis
Faber, F., Thiennimitr, P., Spiga, L., Byndloss, M. X., Litvak, Y., Lawhon, S., Andrews-Polymenis, H. L., Winter, S. E., & Bäumler, A. J. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006129 · Cited by 190
Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans
Pudlo, N. A., Urs, K., Kumar, S. S., German, J. B., Mills, D. A., & Martens, E. C. (2015) · mBio · doi:10.1128/mbio.01282-15 · Cited by 187
“Symbionts such as Bacteroides thetaiotaomicron can liberate sialic acid from host glycoconjugates, providing a sugar that it cannot use itself to pathogens such as Salmonella enterica and Clostridium difficile (23).”
BackgroundHost-mediated sugar oxidation promotes post-antibiotic pathogen expansion
Faber, F., Tran, L., Byndloss, M. X., Lopez, C. A., Velazquez, E. M., Kerrinnes, T., Nuccio, S.-P., Wangdi, T., Fiehn, O., Tsolis, R. M., et al. (2016) · Nature · doi:10.1038/nature18597 · Cited by 180
Roles of the intestinal microbiota in pathogen protection
Ubeda, C., Djukovic, A., & Isaac, S. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.2 · Cited by 181
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
McKenney, P. T., & Pamer, E. G. (2015) · Cell · doi:10.1016/j.cell.2015.11.032 · Cited by 181
Tailford, L. E., Owen, C. D., Walshaw, J., Crost, E. H., Hardy-Goddard, J., Le Gall, G., de Vos, W. M., Taylor, G. L., & Juge, N. (2015) · Nature Communications · doi:10.1038/ncomms8624 · Cited by 183
The Impact of the Milk Glycobiome on the Neonate Gut Microbiota
Pacheco, A. R., Barile, D., Underwood, M. A., & Mills, D. A. (2015) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-111112 · Cited by 180
“Most enteric pathogenic bacteriadonot harbora glycolyticpotential to catabolize complex sugars and rely on free monosaccharides that are made available by the microbiota (123, 124).”
BackgroundIntestinal Fucose as a Mediator of Host–Microbe Symbiosis
Pickard, J. M., & Chervonsky, A. V. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500395 · Cited by 179
“typhimurium, the answer is not clear: in different experimental settings (different bacterial strains and mouse models), bacteria that could not metabolize fucose had either a slight reduction in fecal levels compared with wild-type (46) or not (47).”
BackgroundMicrobiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of the Gut Ecosystem
Maier, L., Vyas, R., Cordova, C. D., Lindsay, H., Schmidt, T. S. B., Brugiroux, S., Periaswamy, B., Bauer, R., Sturm, A., Schreiber, F., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.002 · Cited by 184
Experimental models to study intestinal microbes–mucus interactions in health and disease
Etienne-Mesmin, L., Chassaing, B., Desvaux, M., De Paepe, K., Gresse, R., Sauvaitre, T., Forano, E., de Wiele, T. V., Schüller, S., Juge, N., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz013 · Cited by 178
Gerritsen, J., Hornung, B., Renckens, B., van Hijum, S. A. F. T., Martins dos Santos, V. A. P., Rijkers, G. T., Schaap, P. J., de Vos, W. M., & Smidt, H. (2017) · PeerJ · doi:10.7717/peerj.3698 · Cited by 168
Dynamics and Establishment of Clostridium difficile Infection in the Murine Gastrointestinal Tract
Koenigsknecht, M. J., Theriot, C. M., Bergin, I. L., Schumacher, C. A., Schloss, P. D., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.02768-14 · Cited by 171
Karav, S., Le Parc, A., Leite Nobrega de Moura Bell, J. M., Frese, S. A., Kirmiz, N., Block, D. E., Barile, D., & Mills, D. A. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00547-16 · Cited by 168
Disruption of the gut ecosystem by antibiotics.
Yoon, M. Y., & Yoon, S. S. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.1.4 · Cited by 175
“In addition, when normal mice were treated with streptomycin relatively more sialic acid was produced and increases in the expression of genes related to sialic acid metabolism were identified in the group treated with the antibiotic.(49) Another study reported that C.”
BackgroundResultShigella sonnei Encodes a Functional T6SS Used for Interbacterial Competition and Niche Occupancy
Anderson, M. C., Vonaesch, P., Saffarian, A., Marteyn, B. S., & Sansonetti, P. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.05.004 · Cited by 174
Eberl, C., Weiss, A. S., Jochum, L. M., Durai Raj, A. C., Ring, D., Hussain, S., Herp, S., Meng, C., Kleigrewe, K., Gigl, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.004 · Cited by 170
Evolutionary conservation of the antimicrobial function of mucus: a first defence against infection
Bakshani, C. R., Morales-Garcia, A. L., Althaus, M., Wilcox, M. D., Pearson, J. P., Bythell, J. C., & Burgess, J. G. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0057-2 · Cited by 159
Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut
Reese, A. T., Cho, E. H., Klitzman, B., Nichols, S. P., Wisniewski, N. A., Villa, M. M., Durand, H. K., Jiang, S., Midani, F. S., Nimmagadda, S. N., et al. (2018) · eLife · doi:10.7554/elife.35987 · Cited by 173
Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and Disease
Ohland, C. L., & Jobin, C. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.004 · Cited by 172
“These pathogens exploit the vacant nutrient niche to establish themselves in the intestinal tract and initiate inflammation.(122) Theoretically, a pathobiont could also take advantage of increased sugar access to expand and cause pathology, similar to how Bilophila wadsworthia blooms when supplied with the bile acid t…”
BackgroundSialidases from gut bacteria: a mini-review
Juge, N., Tailford, L., & Owen, C. D. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150226 · Cited by 162
Enterobacteriaceae in the Human Gut: Dynamics and Ecological Roles in Health and Disease
de Gouveia, M. I. M., Bernalier‐Donadille, A., & Jubelin, G. (2024) · Biology · doi:10.3390/biology13030142 · Cited by 213
Battaglioli, E. J., Hale, V. L., Chen, J., Jeraldo, P., Ruiz-Mojica, C., Schmidt, B. A., Rekdal, V. M., Till, L. M., Huq, L., Smits, S. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7019 · Cited by 172
Self-citationNuccio, S.-P., & Bäumler, A. J. (2014) · mBio · doi:10.1128/mbio.00929-14 · Cited by 171
Pathogens, microbiome and the host: emergence of the ecological Koch's postulates
Vonaesch, P., Anderson, M., & Sansonetti, P. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy003 · Cited by 170
“In turn, this acid is metabolized by C. difficile and S. Typhimurium as an alternative 425 nutrient source giving them a selective nutritional advantage over neighbouring bacteria (Ng et al. 2013; Huang et 426 al.”
BackgroundNavigating the Gut Buffet: Control of Polysaccharide Utilization in Bacteroides spp.
Schwalm, N. D., & Groisman, E. A. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.06.009 · Cited by 167
“Moreover, sialic acids released from the host mucosal layer can serve as a carbon source for opportunistic pathogens, such as Salmonella enterica serovar Typhimurium and Clostridium difficile [29,30].”
BackgroundA comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
Clooney, A. G., Bernstein, C. N., Leslie, W. D., Vagianos, K., Sargent, M., Laserna‐Mendieta, E. J., Claesson, M. J., & Targownik, L. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13568 · Cited by 166
Rojo, D., Méndez-García, C., Raczkowska, B. A., Bargiela, R., Moya, A., Ferrer, M., & Barbas, C. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw046 · Cited by 157
Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163
“difficile bacterial load [34].”
Impact of Microbiome on Ocular Health
Kugadas, A., & Gadjeva, M. G. (2016) · The Ocular Surface · doi:10.1016/j.jtos.2016.04.004 · Cited by 172
The microbial ecology of Escherichia coli in the vertebrate gut
Foster-Nyarko, E., & Pallen, M. J. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac008 · Cited by 180
When pathogenic bacteria meet the intestinal microbiota
Rolhion, N., & Chassaing, B. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0504 · Cited by 160
Wacklin, P., Tuimala, J., Nikkilä, J., Tims, S., Mäkivuokko, H., Alakulppi, N., Laine, P., Rajilic-Stojanovic, M., Paulin, L., de Vos, W. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094863 · Cited by 160
Dogan, B., Suzuki, H., Herlekar, D., Sartor, R. B., Campbell, B. J., Roberts, C. L., Stewart, K., Scherl, E. J., Araz, Y., Bitar, P. P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000183 · Cited by 158
“recently been demonstrated that fucose facilitates expansion of Salmonella typhimurium within the human gut.(61) E.”
BackgroundSynthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
Ozdemir, T., Fedorec, A. J. H., Danino, T., & Barnes, C. P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.008 · Cited by 159
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
Khoruts, A., Staley, C., & Sadowsky, M. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0350-4 · Cited by 155
Host–microbe interactions shaping the gastrointestinal environment
Kaiko, G. E., & Stappenbeck, T. S. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.08.002 · Cited by 180
Osbelt, L., Wende, M., Almási, É., Derksen, E., Muthukumarasamy, U., Lesker, T. R., Galvez, E. J. C., Pils, M. C., Schalk, E., Chhatwal, P., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.003 · Cited by 145
Buonomo, E. L., Cowardin, C. A., Wilson, M. G., Saleh, M. M., Pramoonjago, P., & Petri, W. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.007 · Cited by 155
Metabolism of Sialic Acid by Bifidobacterium breve UCC2003
Egan, M., O'Connell Motherway, M., Ventura, M., & van Sinderen, D. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01114-14 · Cited by 151
Human Gut Microbiota: Toward an Ecology of Disease
Selber-Hnatiw, S., Rukundo, B., Ahmadi, M., Akoubi, H., Al-Bizri, H., Aliu, A. F., Ambeaghen, T. U., Avetisyan, L., Bahar, I., Baird, A., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01265 · Cited by 144
Disease Tolerance as an Inherent Component of Immunity
Martins, R., Carlos, A. R., Braza, F., Thompson, J. A., Bastos-Amador, P., Ramos, S., & Soares, M. P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041739 · Cited by 166
Linking microbiota to human diseases: a systems biology perspective
Wu, H., Tremaroli, V., & Bäckhed, F. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.09.011 · Cited by 150
The Pyromaniac Inside You: Salmonella Metabolism in the Host Gut
Rivera-Chávez, F., & Bäumler, A. J. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104108 · Cited by 148
Intestinal colonization resistance in the context of environmental, host, and microbial determinants
Woelfel, S., Silva, M. S., & Stecher, B. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.002 · Cited by 165
Necrotizing Enterocolitis: The Mystery Goes On
Neu, J. (2014) · Neonatology · doi:10.1159/000365130 · Cited by 160
Pang, M., Jiang, J., Xie, X., Wu, Y., Dong, Y., Kwok, A. H. Y., Zhang, W., Yao, H., Lu, C., Leung, F. C.-C., et al. (2015) · Scientific Reports · doi:10.1038/srep09833 · Cited by 141
Wotzka, S. Y., Nguyen, B. D., & Hardt, W. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.009 · Cited by 153
Zhao, C., Wu, K., Hao, H., Zhao, Y., Bao, L., Qiu, M., He, Y., He, Z., Zhang, N., Hu, X., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00374-8 · Cited by 154
Lopez, C. A., Rivera-Chávez, F., Byndloss, M. X., & Bäumler, A. J. (2015) · Infection and Immunity · doi:10.1128/iai.00351-15 · Cited by 140
Regulation of Virulence ofEntamoeba histolytica
Marie, C. S., & Petri, W. A. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091313-103550 · Cited by 157
Vogt, S. L., Peña-Díaz, J., & Finlay, B. B. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.05.002 · Cited by 160
Passmore, I. J., Letertre, M. P. M., Preston, M. D., Bianconi, I., Harrison, M. A., Nasher, F., Kaur, H., Hong, H. A., Baines, S. D., Cutting, S. M., et al. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007191 · Cited by 138
Jenior, M. L., Leslie, J. L., Young, V. B., & Schloss, P. D. (2017) · mSystems · doi:10.1128/msystems.00063-17 · Cited by 144
Ravcheev, D. A., & Thiele, I. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00111 · Cited by 148
Porter, N. T., Luis, A. S., & Martens, E. C. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.005 · Cited by 139
Exploiting host immunity: the Salmonella paradigm
Behnsen, J., Perez-Lopez, A., Nuccio, S.-P., & Raffatellu, M. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.003 · Cited by 138
Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria
Richardson†, A. R., Somerville†, G. A., & Sonenshein†, A. L. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0004-2014 · Cited by 123
Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis
Kugadas, A., Christiansen, S. H., Sankaranarayanan, S., Surana, N. K., Gauguet, S., Kunz, R. C., Fichorova, R. N., Vorup‐Jensen, T., & Gadjeva, M. G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005855 · Cited by 145
Zakharzhevskaya, N. B., Vanyushkina, A., Altukhov, I. A., Shavarda, A. L., Butenko, I., Rakitina, D. V., Nikitina, A. S., Manolov, A. I., Egorova, A. N., Kulikov, E. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05264-6 · Cited by 143
A small-molecule antivirulence agent for treating Clostridium difficile infection
Bender, K. O., Garland, M., Ferreyra, J. A., Hryckowian, A. J., Child, M. A., Puri, A. W., Solow-Cordero, D. E., Higginbottom, S. K., Segal, E., Banaei, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9103 · Cited by 136
Self-citationPalmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00114 · Cited by 133
Extrinsic factors influencing gut microbes, the immediate consequences and restoring eubiosis
Bajinka, O., Tan, Y., Abdelhalim, K. A., Özdemir, G., & Qiu, X. (2020) · AMB Express · doi:10.1186/s13568-020-01066-8 · Cited by 140
Mechanisms by which gut microorganisms influence food sensitivities
Caminero, A., Meisel, M., Jabri, B., & Verdu, E. F. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0064-z · Cited by 129
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases
van den Elsen, L. W., Poyntz, H. C., Weyrich, L. S., Young, W., & Forbes‐Blom, E. E. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2016.91 · Cited by 126
The influence of antibiotics and dietary components on gut microbiota
Dudek-Wicher, R. K., Junka, A., & Bartoszewicz, M. (2018) · Gastroenterology Review · doi:10.5114/pg.2018.76005 · Cited by 151
Human Clostridium difficile infection: altered mucus production and composition
Engevik, M. A., Yacyshyn, M. B., Engevik, K. A., Wang, J., Darien, B., Hassett, D. J., Yacyshyn, B. R., & Worrell, R. T. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2014 · Cited by 135
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review
Pilmis, B., Monnier, A. L., & Zahar, J. (2020) · Microorganisms · doi:10.3390/microorganisms8020269 · Cited by 133
Eun, C. S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I. M., & Sartor, R. B. (2014) · Infection and Immunity · doi:10.1128/iai.01513-13 · Cited by 124
Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica
Nakada‐Tsukui, K., & Nozaki, T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00175 · Cited by 141
Metadata
- Authors
- Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., & Sonnenburg, J. L.
- Affiliations
- Stanford Medicine (US)
- Mayo Clinic (US)
- University of California San Diego (US)
- University of California, Davis (US)
- Corresponding author
- Sonnenburg, Justin L.
- ORCID
- Venue
- Nature
- Published
- 2013-09-01
- Volume
- 502
- Issue
- 7469
- Pages
- 96-99
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3825626
- OpenAlex
- W2026894676
- Cited by
- 1,035
- References
- 40
- Citations by year
- 2026: 57 · 2025: 75 · 2024: 93 · 2023: 61 · 2022: 81 · 2021: 74 · 2020: 90 · 2019: 59 · 2018: 89 · 2017: 91 · 2016: 84 · 2015: 78 · 2014: 95 · 2013: 8
- FWCI
- 39.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI089722, T32AI007328)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085025)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- gut microbiota, antibiotic-associated infection, enteric pathogens, Salmonella typhimurium, Clostridium difficile, sialic acid, Bacteroides thetaiotaomicron, neuraminidase, fucose, sialic acid catabolism, gnotobiotic mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Enterocolitis, Pseudomembranous, Female, Fucose, Intestinal Mucosa, Male, Neuraminidase, Salmonella Infections, Salmonella typhimurium, Specific Pathogen-Free Organisms, Gene Expression Regulation, Bacterial, Clostridioides difficile, N-Acetylneuraminic Acid, Gene Expression Profiling, Carbohydrate Metabolism, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.